Meros Investment Management LP Grows Position in Mesa Laboratories, Inc. $MLAB

Meros Investment Management LP lifted its holdings in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) by 11.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 85,017 shares of the medical instruments supplier’s stock after buying an additional 8,540 shares during the period. Mesa Laboratories makes up 2.6% of Meros Investment Management LP’s portfolio, making the stock its 15th biggest position. Meros Investment Management LP owned about 1.54% of Mesa Laboratories worth $6,674,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of MLAB. Royal Bank of Canada boosted its position in shares of Mesa Laboratories by 1.2% during the first quarter. Royal Bank of Canada now owns 30,772 shares of the medical instruments supplier’s stock valued at $3,652,000 after buying an additional 353 shares during the last quarter. Jacobs Levy Equity Management Inc. purchased a new position in Mesa Laboratories in the first quarter worth about $335,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Mesa Laboratories by 4.9% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 3,068 shares of the medical instruments supplier’s stock valued at $364,000 after purchasing an additional 143 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in shares of Mesa Laboratories by 3.6% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 19,977 shares of the medical instruments supplier’s stock valued at $2,370,000 after purchasing an additional 685 shares during the period. Finally, American Century Companies Inc. grew its stake in shares of Mesa Laboratories by 1.5% during the 2nd quarter. American Century Companies Inc. now owns 13,431 shares of the medical instruments supplier’s stock valued at $1,265,000 after purchasing an additional 194 shares during the period. 90.60% of the stock is owned by hedge funds and other institutional investors.

Mesa Laboratories Trading Down 1.3%

Mesa Laboratories stock opened at $104.08 on Tuesday. The business has a 50-day simple moving average of $101.71 and a two-hundred day simple moving average of $90.40. The company has a market cap of $574.52 million, a P/E ratio of 86.73 and a beta of 0.94. Mesa Laboratories, Inc. has a 52-week low of $55.45 and a 52-week high of $113.99. The company has a quick ratio of 1.29, a current ratio of 1.72 and a debt-to-equity ratio of 0.78.

Mesa Laboratories (NASDAQ:MLAB) last released its quarterly earnings results on Wednesday, May 27th. The medical instruments supplier reported $1.53 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.78 by ($0.25). Mesa Laboratories had a net margin of 2.69% and a return on equity of 20.96%. The firm had revenue of $63.72 million for the quarter, compared to the consensus estimate of $65.21 million. During the same quarter in the prior year, the firm earned ($1.31) earnings per share.

Mesa Laboratories Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, June 15th. Stockholders of record on Friday, May 29th were given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend was Friday, May 29th. Mesa Laboratories’s payout ratio is presently 53.33%.

Wall Street Analyst Weigh In

Separately, Weiss Ratings downgraded Mesa Laboratories from a “sell (d+)” rating to a “sell (d)” rating in a research note on Wednesday, June 3rd. Two research analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Reduce” and a consensus price target of $94.00.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc (NASDAQ: MLAB) is a global provider of instrumentation products designed for critical process monitoring, testing and calibration. Headquartered in Lakewood, Colorado, the company serves a diverse set of end markets including healthcare, pharmaceutical, food and beverage, energy and industrial sectors. With a focus on precision measurement and validation, Mesa Laboratories helps customers ensure regulatory compliance, product safety and operational efficiency across complex manufacturing and sterilization processes.

The company’s product portfolio encompasses biological and chemical indicators for sterilization process validation, digital data loggers and sensors for environmental monitoring, and optical gas analyzers with sample-conditioning solutions for oil, gas and petrochemical applications.